Literature DB >> 7940596

bcl-2 expression decreases methyl mercury-induced free-radical generation and cell killing in a neural cell line.

T A Sarafian1, L Vartavarian, D J Kane, D E Bredesen, M A Verity.   

Abstract

Methyl mercury neurotoxicity is associated with a broad range of neuropathologic and biochemical disturbances which include induction of oxidative injury. Treatment of the hypothalamic neural cell line GT1-7 with 10 microM methyl mercury (MeHg) for 3 h resulted in increased formation of reactive oxygen species (ROS), and decreased levels of reduced glutathione (GSH), associated with 20% cell death. Cells transfected with an expression construct for the anti-apoptotic proto-oncogene, bcl-2, displayed attenuated ROS induction and negligible cell death. Twenty-four-h exposure to 5 microM MeHg killed 56% of control cells, but only 19% of bcl-2-transfected cells. By using diethyl maleate to deplete cells of GSH, we demonstrate that the differential sensitivity to MeHg was not due solely to intrinsically different GSH levels. The data suggest that MeHg-mediated cell killing correlates more closely with ROS generation than with GSH levels and that bcl-2 protects MeHg-treated cells by suppressing ROS generation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7940596     DOI: 10.1016/0378-4274(94)90093-0

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  23 in total

1.  Methylmercury Affects the Expression of Hypothalamic Neuropeptides That Control Body Weight in C57BL/6J Mice.

Authors:  Beatriz Ferrer; Tanara Vieira Peres; Alessandra Antunes Dos Santos; Julia Bornhorst; Patricia Morcillo; Cinara Ludvig Gonçalves; Michael Aschner
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

2.  Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2.

Authors:  D Offen; I Ziv; H Panet; L Wasserman; R Stein; E Melamed; A Barzilai
Journal:  Cell Mol Neurobiol       Date:  1997-06       Impact factor: 5.046

3.  Contrasting antioxidant and cytotoxic effects of peroxiredoxin I and II in PC12 and NIH3T3 cells.

Authors:  S Simzar; R Ellyin; H Shau; T A Sarafian
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

4.  Attenuation of Glutamate-Induced Excitotoxicity by Withanolide-A in Neuron-Like Cells: Role for PI3K/Akt/MAPK Signaling Pathway.

Authors:  Nawab John Dar; Naresh Kumar Satti; Prabhu Dutt; Abid Hamid; Muzamil Ahmad
Journal:  Mol Neurobiol       Date:  2017-04-26       Impact factor: 5.590

5.  Role of oxidative stress and the mitochondrial permeability transition in methylmercury cytotoxicity.

Authors:  Marianne Polunas; Alycia Halladay; Ronald B Tjalkens; Martin A Philbert; Herbert Lowndes; Kenneth Reuhl
Journal:  Neurotoxicology       Date:  2011-08-19       Impact factor: 4.294

6.  Gene expression profiling of diabetic and galactosaemic cataractous rat lens by microarray analysis.

Authors:  E Kubo; D P Singh; Y Akagi
Journal:  Diabetologia       Date:  2005-03-11       Impact factor: 10.122

Review 7.  Neurotoxicity of organomercurial compounds.

Authors:  Coral Sanfeliu; Jordi Sebastià; Rosa Cristòfol; Eduard Rodríguez-Farré
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms.

Authors:  J Roy; S Minotti; L Dong; D A Figlewicz; H D Durham
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Bcl-2 sensitivity differentiates two pathways for motoneuronal death in the wobbler mutant mouse.

Authors:  M Coulpier; M P Junier; M Peschanski; P A Dreyfus
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

10.  Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro.

Authors:  Theodore A Sarafian; Cindy Montes; Tetsuya Imura; Jingwei Qi; Giovanni Coppola; Daniel H Geschwind; Michael V Sofroniew
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.